DIAGNOSTIC PECULARITIES OF METASTASES IN ASCITIC AND PLEURAL FLUID WITH THE USE OF IMMUNOCYTOCHEMICAL METHOD IN PATIENTS WITH SEROUS OVARY CANCER

O. G Grigoruk; V. N Bogatyrev; L. M Bazulina; T. A Maksimenko; A. F Lazarev

doi:10.17816/onco39934

Russian Journal of Oncology ›› 2013, Vol. 18 ›› Issue (1) : 4 -9. DOI: 10.17816/onco39934

Articles

research-article

DIAGNOSTIC PECULARITIES OF METASTASES IN ASCITIC AND PLEURAL FLUID WITH THE USE OF IMMUNOCYTOCHEMICAL METHOD IN PATIENTS WITH SEROUS OVARY CANCER

Author information +

History +

PDF

Keywords

serous ovary cancer / ascitic and pleural fluid / immunocytochemical method

Cite this article

Download citation ▾

O. G Grigoruk, V. N Bogatyrev, L. M Bazulina, T. A Maksimenko, A. F Lazarev. DIAGNOSTIC PECULARITIES OF METASTASES IN ASCITIC AND PLEURAL FLUID WITH THE USE OF IMMUNOCYTOCHEMICAL METHOD IN PATIENTS WITH SEROUS OVARY CANCER. Russian Journal of Oncology, 2013, 18(1): 4-9 DOI:10.17816/onco39934

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Карселадзе А. И. Клинико-морфологическая диагностика опухолей яичника. Архив патологии 2005; прил.: 63.

[2]	Alberti N., Serrano-Egea A., Garcia-García E. et al. Primary papillary serous carcinoma of the peritoneum: report of a case with diagnosis by fine needle aspiration and immunocytochemistry. Acta Cytol. 2007; 51 (2): 203—206.

[3]	Dubeau L. The cell of origin of ovarian epithelial tumours. Lancet Oncol. 2008; 9: 1191—1197.

[4]	Davidson B. The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma. Cytopathology. 2011; 22: 5—21.

[5]	Capitanio A., Natula A., Falson M. Diagnostic pitfall of atipical glandular cells with psammoma bodies in peritoneal waching cytology. J. Cytopathol. 2008, 19 (Suppl. 1: 34th European Congress of Cytology, Rovaniemi, Finland): poster 108; 56.

[6]	Григорук О. Г., Лазарев А. Ф., Богатырёв В. Н. Дифференциальная цитологическая диагностика плевритов. Барнаул: ОАО «ИПП "Алтай"», 2012: 122—4.

[7]	Comin C.E., Saieva C., Messerini L. H-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Am. J. Surg. Pathol. 2007; 31 (8): 1139—48.

[8]	McCluggage W. G., Young R. H. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors. Semin. Diagn. Pathol. 2005; 22 (1): 3—32.

[9]	Politi E., Kandaraki C., Apostolopoulou C. et al. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids. Diagn. Cytopathol. 2005; 32: 151—5.

[10]	Su X. Y., Li G. D., Liu W. P. et al. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry. Diagn. Cytopathol. 2010; 10: 123—7.

[11]	Мельник М. М. Імуногістохімічні технології діагностики метастазів анонімної пухлин. Світ медицини та біології. 2008; 2: 48—56.

[12]	Tot T. Cytokeratyns 20 and 7 as biomarkers usefulness in discriminating primary from metastatic adenocarcinoma. Eur. J. Cancer. 2002; 38 (6): 758—63.

[13]	Heintz A. P., Odicino F., Maisonneuve P. et al. Carcinoma of the ovary FIGO. Int. J. Gynaecol. Obstetr. 2006; 95 (Suppl. 1: 6th Annual report on the results of treatment in gynecological cancer): 161—92.

[14]	Hylander B., Repasky E., Shrikant P. et al. Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer. Gynecol. Oncol. 2006; 101: 12—7.

[15]	Zhu W., Michael C. Wt1, Monoclonal CEA, TTF1, and CA125 antibodies in the differencial diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions. Diagn. Cytopathol. 2007; 35 (6): 370—5.

[16]	Sopel M., Surowiak P., Berdowska I. Nuclear maspin expression as a good prognostic factor in human epithelial ovarian carcinoma. Folia Morphol. 2010; 69 (4): 204—12.